{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:18:25Z","timestamp":1787807905555,"version":"build-2784847793"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bloodstream infections (BSIs) are serious complications in patients with hematologic malignancies (HMs) and are associated with substantial morbidity and mortality. Effective risk stratification is crucial for optimizing empirical antimicrobial decisions. This study aimed to develop and internally validate nomograms for predicting BSI occurrence and post-BSI mortality among HM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study enrolled 3,014 HM patients, including 725 with BSI. The cohort was randomly divided into derivation and internal validation cohorts at a 6:4 ratio. The BSI occurrence model was developed using multivariable logistic regression, while the post-BSI mortality prediction model among patients with BSI was developed using Cox regression. Model performance was evaluated based on discrimination, calibration, and decision curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The BSI occurrence model demonstrated acceptable discrimination, with area under the receiver operating characteristic curve (AUC) values of 0.775 in the derivation cohort and 0.761 in the internal validation cohort. The final nomogram incorporated 12 variables, among which neutrophil count \u22640.5 \u00d7 10\n                      <jats:sup>9<\/jats:sup>\n                      \/L received a relatively high point allocation. The post-BSI mortality prediction nomogram showed moderate discrimination, with C-indices of 0.721 and 0.713 in the derivation and internal validation cohorts, respectively. Nine variables were included in the final post-BSI mortality model, and polymicrobial BSI received a relatively high point allocation within the nomogram. Both models demonstrated acceptable calibration and potential clinical utility based on decision curve analysis. The BSI occurrence model was further assessed in a small independent cohort, whereas the mortality model requires additional external validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The BSI occurrence model showed acceptable discrimination in the derivation and internal validation cohorts and was preliminarily assessed in an independent cohort. The post-BSI mortality model showed moderate discrimination in the internal validation cohort and requires further evaluation in larger and more representative populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1834653","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:27:21Z","timestamp":1787804841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A multidimensional nomogram for clinical risk stratification of bloodstream infection and mortality in hematologic malignancies"],"prefix":"10.3389","volume":"16","author":[{"given":"Lingqiong","family":"Lan","sequence":"first","affiliation":[{"name":"The Second Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]},{"name":"Department of Hematology, Longyan Second Hospital","place":["Longyan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhen","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]},{"name":"Fujian Medical University Cancer Hospital, Fujian Cancer Hospital","place":["Fuzhou, China"]},{"name":"Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Zhu","sequence":"additional","affiliation":[{"name":"The Second Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]},{"name":"The Second Department of Hematology, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Fan","sequence":"additional","affiliation":[{"name":"The Second Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]},{"name":"The Second Department of Hematology, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Kong","sequence":"additional","affiliation":[{"name":"The Second Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]},{"name":"The Second Department of Hematology, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Ren","sequence":"additional","affiliation":[{"name":"The Second Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]},{"name":"The Second Department of Hematology, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianda","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital","place":["Fuzhou, China"]},{"name":"The Second Affiliated Hospital of Fujian Medical University","place":["Quanzhou, China"]},{"name":"Institute of Precision Medicine, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[{"name":"The Second Department of Hematology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]},{"name":"Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital","place":["Fuzhou, China"]},{"name":"The Second Department of Hematology, The First Affiliated Hospital, Fujian Medical University","place":["Fuzhou, China"]},{"name":"Institute of Precision Medicine, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107403","article-title":"Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy","volume":"204","author":"Abdel-Azim","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2024-001289","article-title":"Impact of inappropriate empirical antibiotic therapy on in-hospital mortality: a retrospective multicentre cohort study of patients with bloodstream infections in Chile 2018-2022","volume":"2","author":"Allel","year":"2024","journal-title":"BMJ Public Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1186\/s40001-025-02858-z","article-title":"Multinational association for supportive care in cancer (MASCC) versus clinical index of stable febrile neutropenia (CISNE): evaluation of predictive performance and clinical utility in patients with febrile neutropenia","volume":"30","author":"Alpar","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12879-021-06243-z","article-title":"Bloodstream infections in adult patients with Malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance","volume":"21","author":"Amanati","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/oncolo\/oyac074","article-title":"Chemotherapy-induced neutropenia and febrile neutropenia in the US: a beast of burden that needs to be tamed","volume":"27","author":"Boccia","year":"2022","journal-title":"Oncologist"},{"key":"B6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11739-024-03692-7","article-title":"Bloodstream infections due to multi-drug resistant bacteria in the emergency department: prevalence, risk factors and outcomes-a retrospective observational study","volume":"20","author":"Capsoni","year":"2025","journal-title":"Intern. Emerg. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.7150\/jca.50802","article-title":"A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological Malignancy patients receiving chemotherapy","volume":"12","author":"Chen","year":"2021","journal-title":"J. Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1561587","article-title":"Incidence and risk factors of active carbapenem-resistant enterobacteriaceae surveillance in hematology patients: a propensity score matching study","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"40013","DOI":"10.1038\/s41598-025-23770-w","article-title":"Inflammatory markers predict bloodstream infections risk in hematological Malignancy patients with chemotherapy induced neutropenia","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"key":"B10","volume-title":"Performance standards for antimicrobial susceptibility testing","year":"2023"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/jac\/dkae093","article-title":"A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study","volume":"79","author":"De la Rosa-Riestra","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jiph.2023.11.017","article-title":"Dissecting bloodstream infections in febrile neutropenic patients with hematological Malignancies, a decade-long single center retrospective observational study, (2009-2019)","volume":"17","author":"El","year":"2024","journal-title":"J. Infect. Public Health"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106919","article-title":"Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI study","volume":"62","author":"Erdem","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01005-21","article-title":"Blood culture utilization in the hospital setting: a call for diagnostic stewardship","volume":"60","author":"Fabre","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199531","article-title":"Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance","volume":"13","author":"Garcia-Vidal","year":"2018","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1597047","article-title":"Timing of antibiotic initiation in sepsis and neutropenic fever","volume":"12","author":"Gretland","year":"2025","journal-title":"Front. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1186\/s12879-025-11815-4","article-title":"Development and validation of a nomogram for predicting PICC catheter-related bloodstream infection among patients with hematologic Malignancies","volume":"25","author":"Guo","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1097\/INF.0000000000001106","article-title":"Understanding bacterial isolates in blood culture and approaches used to define bacteria as contaminants: a literature review","volume":"35","author":"Hossain","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbmt.2015.09.019","article-title":"High incidence of afebrile bloodstream infection detected by surveillance blood culture in patients on corticosteroid therapy after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Kameda","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15151922","article-title":"Improving prognostic accuracy of MASCC score with lactate and CRP measurements in febrile neutropenic patients","volume":"15","author":"Kanter","year":"2025","journal-title":"Diagnostics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.51620\/0869-2084-2022-67-6-355-361","article-title":"Bloodstream infection in hospital therapeutic patients","volume":"67","author":"Kargaltseva","year":"2022","journal-title":"Klin. Lab. Diagn."},{"key":"B22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cmi.2019.10.031","article-title":"Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens","volume":"26","author":"Kern","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cmi.2019.11.017","article-title":"Bloodstream infections - standard and progress in pathogen diagnostics","volume":"26","author":"Lamy","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1570792","article-title":"Global, regional, and national economic burden of hematologic Malignancies, (1990-2021) with projections to 2050","volume":"13","author":"Li","year":"2025","journal-title":"Front. Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12879-025-10808-7","article-title":"Machine learning-based prognostic model for bloodstream infections in hematological Malignancies using th1\/th2 cytokines","volume":"25","author":"Li","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis","volume":"196","author":"Liu","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B27","volume-title":"Opetating procedures of blood culture for clinical microbiology laboratory","year":"2017"},{"key":"B28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s12185-021-03183-x","article-title":"Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study","volume":"114","author":"Okamoto","year":"2021","journal-title":"Int. J. Hematol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae282","article-title":"Association between infectious diseases consultation and mortality in hospitalized patients with gram-negative bloodstream infection: a retrospective population-wide cohort study","author":"Ong","year":"2024","journal-title":"Clin. Infect. Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15622","DOI":"10.1038\/s41598-024-66524-w","article-title":"Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections","volume":"14","author":"Park","year":"2024","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MPH.0000000000002974","article-title":"Machine learning-based prediction of blood stream infection in pediatric febrile neutropenia","volume":"47","author":"Park","year":"2025","journal-title":"J. Pediatr. Hematology\/Oncology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1007\/s10238-023-01206-x","article-title":"Bloodstream infections in neutropenic and non-neutropenic patients with haematological Malignancies: epidemiological trends and clinical outcomes in queensland, Australia over the last 20 years","volume":"23","author":"Peri","year":"2023","journal-title":"Clin. Exper. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/14787210.2020.1820863","article-title":"Management of fever and neutropenia in the adult patient with acute myeloid leukemia","volume":"19","author":"Peseski","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2899","article-title":"Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1128\/JCM.40.7.2437-2444.2002","article-title":"Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm","volume":"40","author":"Richter","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmi.2022.07.011","article-title":"Concurrent external validation of bloodstream infection probability models","volume":"29","author":"Rodic","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"B37","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/14787210.2019.1573670","article-title":"Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation","volume":"17","author":"Schmidt-Hieber","year":"2019","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.21203\/rs.3.rs-322271\/v1","article-title":"Comparison of CISNE and MASCC score in predicting complications on post chemotherapy febrile neutropenia","volume":"56","author":"Shakinah","year":"2024","journal-title":"Acta Med. Indones."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111616","article-title":"Effect of delayed antibiotic use on mortality outcomes in patients with sepsis or septic shock: a systematic review and meta-analysis","volume":"129","author":"Tang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1167638","article-title":"Microbiology and prognostic prediction model of bloodstream infection in patients with hematological Malignancies","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13054-023-04385-x","article-title":"National incidence and mortality of hospitalized sepsis in China","volume":"27","author":"Weng","year":"2023","journal-title":"Crit. Care"},{"key":"B42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ijantimicag.2019.09.015","article-title":"Clinical predictors and outcome impact of community-onset polymicrobial bloodstream infection","volume":"54","author":"Yo","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107769","article-title":"Global and regional burden of bloodstream infections caused by carbapenem-resistant gram-negative bacteria in 2019: a systematic analysis from the MICROBE database","volume":"153","author":"Zha","year":"2025","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. For. Infect. Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1834653\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:27:22Z","timestamp":1787804842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1834653\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":43,"alternative-id":["10.3389\/fcimb.2026.1834653"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1834653","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1834653"}}